Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EUCRATES BIOMEDICAL ACQUISITION CORP.

(EUCR)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/18/2021 11/19/2021 11/22/2021 11/23/2021 11/24/2021 Date
0(c) 9.7883(c) 9.8(c) 9.82(c) 9.8(c) Last
3 100 966 7 003 216 Volume
-100.00% +0.12% +0.20% -0.20% Change
More quotes
Estimated financial data (e) (USD)
Sales 2019
Net income 2019
Net Debt 2019
P/E ratio 2019
Yield 2019
Sales 2020 - - -
Net income 2020 -14,8 M - -
Net cash position 2020 0,55 M - -
P/E ratio 2020 -
Yield 2020 -
Capitalization 132 M 132 M -
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees -
Free-Float 80,5%
More Financials
Company
Eucrates Biomedical Acquisition Corp. is a blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities. The Company intends to focus on... 
Sector
Investment Holding Companies
Calendar
-
More about the company
All news about EUCRATES BIOMEDICAL ACQUISITION CORP.
11/22EUCRATES BIOMEDICAL ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIA..
AQ
11/22Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter an..
CI
11/19EUCRATES BIOMEDICAL ACQUISITION CORP : Non-Reliance on Previous Financials, Audits or Inte..
AQ
08/16EUCRATES BIOMEDICAL ACQUISITION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
07/16EUCRATES BIOMEDICAL ACQUISITION : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
07/16Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the First Quarter En..
CI
07/15EUCRATES BIOMEDICAL ACQUISITION : 10-K/A - Management's Discussion and Analysis of Financi..
AQ
06/21EUCRATES BIOMEDICAL ACQUISITION CORP : Non-Reliance on Previous Financials, Audits or Inte..
AQ
06/01EUCRATES BIOMEDICAL ACQUISITION : Receives Non-Compliance Notice from Nasdaq
MT
06/01EUCRATES BIOMEDICAL ACQUISITION : RECEIVES EXPECTED NOTICE FROM NASDAQ REGARDING DELAYED Q..
PU
06/01EUCRATES BIOMEDICAL ACQUISITION CORP : Notice of Delisting or Failure to Satisfy a Continu..
AQ
04/22Certain Ordinary Shares of Eucrates Biomedical Acquisition Corp. are subject to a Lock-..
CI
03/31EUCRATES BIOMEDICAL ACQUISITION : Management's Discussion and Analysis of Financial Condit..
AQ
03/31Eucrates Biomedical Acquisition Corp. Announces Earnings Results for the Period from Au..
CI
2020EUCRATES BIOMEDICAL ACQUISITION CORP : EUCR) added to NASDAQ Composite Index
CI
More news
News in other languages on EUCRATES BIOMEDICAL ACQUISITION CORP.

- No features available -

More news
Chart EUCRATES BIOMEDICAL ACQUISITION CORP.
Duration : Period :
Eucrates Biomedical Acquisition Corp. Technical Analysis Chart | EUCR | VGG3141W1068 | MarketScreener
Income Statement Evolution
Managers and Directors
Parag Phoolchand Saxena Chief Executive Officer & Director
Evangelos Vergetis President, Chief Operating Officer & Director
Gonzalo Cordova Chief Financial Officer
Stelios Papadopoulos Chairman
Daphne Karydas Independent Director
Sector and Competitors